TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of Participants Achieving Clinical Remission per CDAI Score at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Clinical Remission per Stool Frequency and Abdominal Pain Score at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Endoscopic Response at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Therapeutic toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Time of myelosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Vitamin D levels after one month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vitamin D levels after three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PTH levels after one month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PTH levels after three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cutoff value of APTT/FIB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Progression of HIV disease status: immunological decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Progression of HIV disease status: RNA 1,000 copies/mL or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of HIV disease status: development of an AIDS-defining opportunistic infection or malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: A greater than or equal to two-fold increase in the frequency of responding HIV-1 Gag-specific CD8 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in Overstimulation Sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Fitbit Sleep Data - Time spent awake, restless, and asleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ejection Fraction Percentage (EF%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCτ, SS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early diagnosis of Interstitial lung disease in rheumatoid arthritis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in tricuspid regurgitation severity (scale of 0-5) by echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shoulder Mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of ADCT-701
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in level of interleukin-6 and transforming growth factor beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time spent on medication dispensation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Probability of immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety profile of interventional therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Transfusion independence (TD high cohort)
Endpoint domain: Adverse events/effects
Primary endpoint: Transfusion independence (TD low cohort)
Endpoint domain: Adverse events/effects
Primary endpoint: Anemia response (nTD cohort)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 12-month recurrence-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: 3-month pathological complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy in the treatment of moderate and severe atopic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Sleep duration from baseline to day 22
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in sleep efficiency from baseline to day 22
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in glucose homeostasis after 22 days of Moona Device usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative live birth rate (cLBR)
Endpoint domain: Mortality/survival
Primary endpoint: Tolerability of intra-patient dose escalation
Endpoint domain: Adverse events/effects
Primary endpoint: Induction of drug tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence and severity of solicited local and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence, severity, and relationship to vaccination of unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of adverse events of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Bullous Pemphigoid Disease Area Index (BPDAI) severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post operative surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: MSNA- Burst frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSNA- Burst incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSNA- total activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sinonasal outcome test (SNOT-22) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in University of Pennsylvania Smell Identification Test (UPSIT) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in nasal peak flow (NPF) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Internal validity of the 6 minutes step test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: External validity of the ST6 with respect to the 6 minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of MSSA cross transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dynamic cerebral blood flow autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients adhering to physical activity recommendations
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduction of erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: purpura
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response to SARS-CoV-2 infection or vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Humoral response to SARS-CoV-2 infection or vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cellular response to SARS-CoV-2 infection or vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: pCO2 (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pO2 (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctHb (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SO2, FO2Hb, FCOHb, FMetHb (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cBase(Ecf)c, cHCO,-(P.st)c, cNa, cK, cCl, cCa (mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean area under the net head acceleration vs. time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euclidean distance between planned and actual implanted coordinate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal permeability measured by sugar test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Demographic dimension
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Perioperative depression and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional status and postoperative recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline to the 28-day Average of Daily Sinus Total Symptom Score (sTSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who reported satisfaction with COUNTS program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in Hb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hospitalization due to COVID-19 pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Family Conflict
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change From Baseline in Family Cohesion
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change From Baseline in Cognitive Reappraisal
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Respiratory rate measured by pulmonary function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory rate measured by ventilator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory rate measured by patch-type electrocardiogram device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Provocative pad weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative systolic hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Allergic reactions and hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Respiratory disorders and Respiratory hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Markers of BBB disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating tight junction-related proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onkoneural antibodies in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fatty acid levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fatty acid levels in red blood cell (RBC) membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in circulating biomarker Lipoxin A4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Radiation-induced liver disease (RILD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Renal capsule invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Perirenal fat tissue invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Thickening of the Gerota's fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of occurrence of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolomic signature (Amino acid composition)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of adverse events improvement
Endpoint domain: Adverse events/effects
Primary endpoint: Discharge Disposition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of WGS analysis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plaque score using Modified Dental Plaque (MPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival Score using Modified Gingivitis Plaque (MGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microstate coverage during training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microstate coverage during rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pediatric Anesthesia Emergence Delirium (PAED) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: New or worsening hematologic disorders
Endpoint domain: Adverse events/effects
Primary endpoint: Change in sleep disturbance symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Divided Attention Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sustained Attention Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working Memory Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Completion of LCS counseling
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Diagnostic yield of OCT or R-EBUS-guided TBB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracellular tenofovir diphosphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of ACER-801
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Concentration (Tmax) of ACER-801
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Curve From Dosing to the Time of the Last Measured Concentration (AUClast) of ACER-801
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of cardiac and extra cardiac vascular anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of TNF-α level in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wexner's score evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of EGFR mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Spectral power of central venous pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in food security
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in dietary quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in usual dietary intake of food groups and nutrients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 6-minute walking distance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood disturbance evaluated by the Profile Of Mood States (POMS) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cytokine levels (PG/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Use of free male condoms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Absolute change of FFR values (ΔFFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain of the TMJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete sonographic disappearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative opioid analgesia consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in opioid consumption between the first two dressing changes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ambulatory Self-Confidence Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prosedural Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physiological parameters - Pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters - Oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters - Respiration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle mass gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 50% decrease in grade ≥ 2 neurotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: composite endpoint of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of interventional pain procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent time spent in glucose target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in total sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in the ESS in Arm 1 (≥2 points)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in PSQI at 6 weeks in Arm 1 (≥3 points)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants With a Positive CSSRS Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived Sleep Quality Via Pittsburgh Sleep Quality Index Global Sleep Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep Duration (Mean Daily Hours)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants With at Least 1 Suicidal Behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vitamin B6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Hematological Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Inspiratory neural drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrically evoked compound action potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptomatic and asymptomatic venous thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean malodor intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Optical Coherence Tomography Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cellular maturity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in the time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of the Autism Diagnostic Observation Schedule -2 (ADOS-2), Module 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in glucose infusion rate (GIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in hemoglobin A1c%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of participants with response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of good neurological functional prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients maintaining SpO2 >93% without oxygen support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total serum protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes